^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NSC348884

    i
    Other names: NSC348884
    Company:
    Targeted Cancer Therap
    Drug class:
    Nucleophosmin inhibitor